A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg by Gln in the putative factor‐VIII‐binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele

British Journal of Haematology

Volumn 80, Issue 3, 1992, Pages 358-363

  Peerlinck, Kathelijne ^a   Eikenboom, Jeroen C J ^b   Ploos, Hans K ^a   Amstel, Van ^b   Sangtawesin, Wanida ^a   Arnout, Jef ^a   Reitsma, Pieter H ^b   Vermylen, Jos ^a   Brieut, Ernest ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; MESSENGER RNA; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CASE REPORT; FEMALE; GENETICS; HUMAN; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

ADULT; ALLELES; ARGININE; BASE SEQUENCE; CASE REPORT; FACTOR VIII; FEMALE; GLUTAMINE; HETEROZYGOTE; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; RNA, MESSENGER; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0026557952     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1992.tb08145.x     Document Type: Article

References (29)

1. A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptidc at the amino terminus of the mature vWF polypeptide
2. von Willebrand factor and platelet function
3. Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor/factor VIII interaction
4. A simple and accurate microplate assay for the determination of factor VIII activity
5. Severe type Ill von Willebrand's disease in the Dutch population is often associated with the absence of von Willebrand factor messenger RNA
6. A major factor VIII binding domain resides within the amino‐terminal 272 amino acid residues of von Willebrand factor
7. Factor VIII structure and function
8. The ‘Normandy’ variant of von Willebrand disease. Characterization of a point mutation in the von Willebrand factor gene
9. Identification of two point mutations in the von Willebrand factor gene of three families with the ‘Normandy’ variant of von Willebrand disease
10. Characterization of mutations in the factor VIII gene by direct sequencing of amplified gcnomic DNA
11. Synthesis, processing and secretion of recombinant human factor VIII expressed in mammalian cells
12. Molecular abnormality of the factor VIII‐binding region of von Willebrand factor
13. RsaI polymorphism in von Willebrand factor (vWF) at codon 789
14. Structure of the gene for human von Willebrand factor
15. A new von Willebrand factor defect in a patient with factor VIII deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction
16. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress‐induced platelet aggregation
17. Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease
18. Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression
19. New variant of von Willebrand disease with defective binding to factor VIII
20. Antihemophilic factor: separation of an active fragment following dissociation by salts or detergents
21. Shear‐induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb‐IIIA
22. Intron‐exon organization of the active human protein S gene PSα and its pseudogene PSβ: duplication and silencing during primate evolution
23. The complex multimeric composition of factor VIII/von Willebrand factor
24. Primer‐directed enzymatic amplification of DNA with a thermostable DNA polymerase
25. Isolation of cytoplasmic RNA from mammalian cells
26. Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N‐terminal portion of von Willebrand factor
27. Measurement of von Willebrand factor antigen in plasma and platelets with an enzyme‐linked immunosorbent assay based on two murine monoclonal antibodies
28. Detection of heterozygotes for recessive von Willebrand's disease by the assay of antihemophilic‐factor‐like antigen
29. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttrans‐fusion and dissociated factor VIII in patients with von Willebrand's disease